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1300 Correspondence and communicationsincluded reactions noted in melanoma SNB reported an
incidence of between 0.8% and 1.9%.
The St George’s Hospital Melanoma database of
sentinel node biopsies has been complied since 1998 and
currently has 1785proceduresrecorded. No cases of
anaphylaxis or other life threatening reactions have been
observed. One confirmed adverse reaction to patent blue
dye was noted in our series, a case of blue derma-
graphia.4 This patient required no form of resuscitation
and the procedure was completed without complication.
St George’s Hospital Melanoma Unit therefore demon-
strates an incidence of 0.056% of adverse reactions to
patent blue dye, with no cases of life threatening re-
actions. This is significantly lower than the incidence re-
ported by the ALMANAC trial.
The MHRA advice is based on evidence primarily from
studies observing rates of reactions to patent blue dye in
the setting of SNB for breast cancer. It could be hypothe-
sized that different techniques of administering the dye
such as peritumoural or periariolar5 used in breast cancer
increase the risk of an adverse reaction to the dye when
compared to the intradermal injections used in melanoma
SNB. It may be that sub dermal injections increase systemic
spread of the dye leading to more severe reactions. Simi-
larly SNB for breast cancer is usually undertaken at the
same time as the removal of the malignancy. As malignant
tissues are often more vascular than normal tissue this may
represent a route for greater systemic spread of the dye
when compared to SNB for melanoma where the original
lesion has usually been previously excised for diagnostic
histology. This too may account for the higher rates of
adverse reactions. Furthermore it is uncommon to use more
than 1 ml of the dye in melanoma SNB. This is at least 50%
less dye than the standardized volume of 2.0 ml used for
breast cancer SNB in the ALMANAC study. This reduced
volume may conceivably too affect rates of adverse
reactions.
The risk of adverse reactions to the dye is not routinely
mentioned during the consent process for SNB at St Georges
Hospital. The St Georges Melanoma Unit has not experi-
ences any life threatening reactions to patent blue dye. Our
incidence of 0.056% of adverse reactions, being <1%, means
that we would not routinely include adverse reactions to
patent blue dye as part of our consent procedure. However
individual units must reflect on their own experiences with
patent blue dye and determine whether they should or
should not routinely the risks of adverse reactions during
consent.
Vigilance should always be encouraged however the St
Georges Melanoma Unit’s experiences with patent blue dye
would suggest it is safe having experienced a very low
incidence of adverse reactions when used for melanoma
sentinel node biopsy.
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http://dx.doi.org/10.1016/j.bjps.2013.03.036Cutaneous lymphadenoma
with unusual localization*Dear Sir,
Cutaneous lymphadenoma is a rare epithelial neoplasm
that arises mainly on the skin of the head and neck. It was
first described in 1991 by Santa Cruz et al.1 and has been
reported in the literature under various names e.g. benign
lymphepithelial tumor of the skin and adamantinoid tri-
choblastoma.2 Histological findings have shown a florid
mononuclear cell infiltration in the tumor nests and a
detailed phenotypical analysis of T-cells showed that they
mainly consisted of memory T-cells. As to whether cuta-
neous lymphadenoma is a benign or malignant skin tumor is
under discussion by various authors but it has shown met-
astatic tendency.3 We present a case of a cutaneous lym-
phadenoma with an unusual localization on the lower back
in a 60-year old man.
Figure 2 Immunohistochemical staining for cutaneous
lymphadenoma.
Correspondence and communications 1301Clinical findings
A 60-year old man, otherwise healthy, sought his general
physician because of a slow-growing element on the lower
back. The patient had had the small skin tumor for
approximately 10 years with no complaints except
cosmetic and an increase in size. The GP referred the pa-
tient with an presumed atheroma to a dermatologist for
surgical removal. The clinical findings were a solid tumor
measuring 22  12 mm, pale skin-colored and not well
defined from the adjacent skin. Though the tumor was
excised close to the borders, there was no remaining tumor
after excision.
Histopathological findings
Histologic examination revealed a well-circumscribed
unencapsulated intradermal lesion with multiple irregu-
larly shaped lobules, cords and interconnected strands
with a peripheral palisaded border of basaloid-like cells
and admixture of central mononuclear cells. No connec-
tion with the overlying epidermis on consecutive sections
was found. Areas of central keratinization were also
present. Immunohistochemical stainings revealed that
epithelial cells were positive for PanCK, EP4 (peripheral
border), but negative for EMA. Mononuclear cells within
the lobules and tumor stroma areas were positive for CD3,
CD4, CD5, TIA1. CD1a, CD68 and S-100 stain revealed
some positive cells within the lobules. From the above the
diagnosis of cutaneous lymphadenoma was made
(Figures 1 and 2).
Discussion
Cutaneous lymphadenoma is a very rare neoplasm, which
arises mainly on the skin of the head and neck. More thanFigure 1 Irregularly shaped lobules with a peripheral pali-
saded border of basaloid-like cells and admixture of central
mononuclear cells.40 cases of cutaneous lymphadenoma have been reported
and only few with localization other than head/neck. The
latest WHO classification of tumors considers it to be a
synonym of trichoblastoma (an adamantinoid tricho-
blastoma), but there is still debate regarding pathogen-
esis of this neoplasm. Histologically, cutaneous
lymphadenoma is composed of multiple rounded or
irregularly shaped lobules of basaloid cells with some
degree of peripheral palisading, with an intense infiltrate
of small mature lymphocytes within the lobules. Histo-
pathological differential diagnosis includes clear cell
basal cell carcinoma, clear cell variant of syringoma,
trichoepithelioma, lymphoepithelioma-like carcinoma of
the skin.4 However, the above-mentioned tumors do not
show such prominent lymphoid cell infiltrate within the
tumor lobules.
There is an ongoing discussion as to whether this tumor
is malignant or benign. Complete excision is therefore
recommended. Excision with Mohs surgery has earlier been
shown to be effective and safe.5 Two out of three patients
had the tumor removed in two stages, suggesting the
margins were not clinically well-defined, as was the case
with our patient, although microscopy showed no
remaining tumor. Hanlon et al.5 recommend Mohs as
being ideal for sparing as much of the healthy skin as
possible, while insuring complete removal with highest
cure rate and best cosmetic result, because the defect is
kept as small as possible, especially since the majority
of cutaneous lymphadenomas occur on the face. Mohs
micrographic surgery, though, is expensive and time-
consuming and we simply recommend re-excision if the
margins are not microscopically without tumor. After
complete excision there have been no cases of remission,
so this seems to be a safe and still a minimally invasive
method.
We present a case of cutaneous lymphadenoma with an
unusual localization on the lower back, treated with com-
plete excision, with no reported remission after 2 years.
1302 Correspondence and communicationsLearning points
- Cutaneous lymphadenoma is a rare skin tumor of the
neck and head, but it can also be seen on the legs or
trunk.
- Re-excision if the margins are not microscopically free
of tumor.
- Histologically, characterized by multiple rounded or
irregularly shaped lobules of basaloid cells with some
degree of peripheral palisading, with an intense
infiltrate of small mature lymphocytes within the
lobules.
- Clinically it can resemble an atheroma and histologi-
cally basal cell carcinoma, clear cell syringoma or
lymphoepithelioma-like carcinoma.Disclosures
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Ladegårdsgade 3, 9100 Aalborg, DenmarkFigure 1 Fluoroscopic-guided depth gauge placement. The
depth gauge lip can clearly be seen to be accurately placed.ª 2013 British Association of Plastic, Reconstructive and Aesthetic
Surgeons. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.bjps.2013.04.033A simple technique using
the mini C-arm to guide
depth gauge placementDear Sir,
Open plate-fixation of hand fractures relies upon efficient,
accurate and safe insertion of the plate and screws. Screw
length is ascertained using a depth gauge and, although
depth gauge measurement may be certain in most cases,
we have found that this is not true in some instances such
as with more complex fracture patterns. This can result in
several different measurements being made and subse-
quent incorrect screw length selection.
We present a simple technique that utilises the mini C-
arm in conjunction with a depth gauge to assist accurate
drill hole depth measurement in cases where doubt exists
using the gauge alone.
This technique is used after guided hole drilling of the
bone has been performed. Where there is measurement
doubt using the depth gauge, we advocate that depth
gauge insertion is accompanied by visual confirmation of
accurate placement using the mini C-arm orientated
perpendicular to the axis of the screw hole to obtain a
screening image (Figure 1).
This uniquely described simple technique for drill hole
depth measurement and screw choice in metacarpal frac-
ture plate fixation prevents potentially unnecessary second
screening after incorrect screw length placement with
subsequent requirement for removal and reinsertion. This is
due to direct visualisation of the depth gauge ‘lip’ as it has
made contact with the deep volar cortex, and provides
accurate measurement at the first attempt. It provides a
visual reference image for subsequent drilled holes so that
the likely depth may be anticipated, and thus rule out
subsequent inaccurate drill hole measurements.
In cases with more complex fracture patterns the small
‘lip’ of the depth gauge may in fact miss the deeper volar
